Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protocol for CRISPR-Cas9-mediated induction of KMT2A rearrangements in cell line and umbilical cord blood hematopoietic stem and progenitor cells.
Benz T, Larghero P, Meyer C, Müller M, Brüggmann D, Hentrich AE, Louwen F, Erkner E, Fitzel R, Schneidawind C, Marschalek R. Benz T, et al. Among authors: larghero p. STAR Protoc. 2024 Dec 17;6(1):103481. doi: 10.1016/j.xpro.2024.103481. Online ahead of print. STAR Protoc. 2024. PMID: 39700011 Free article.
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome.
Külp M, Larghero P, Alten J, Cario G, Eckert C, Caye-Eude A, Cavé H, Schmachtel T, Bardini M, Cazzaniga G, De Lorenzo P, Valsecchi MG, Bonig H, Meyer C, Rieger MA, Marschalek R. Külp M, et al. Among authors: larghero p. Leukemia. 2023 Jun;37(6):1216-1233. doi: 10.1038/s41375-023-01895-z. Epub 2023 Apr 26. Leukemia. 2023. PMID: 37100882 Free PMC article.
Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia.
Maurer-Granofszky M, Kohrer S, Fischer S, Schumich A, Nebral K, Larghero P, Meyer C, Mecklenbrauker A, Muhlegger N, Marschalek R, Haas OA, Panzer-Grumayer R, Dworzak MN. Maurer-Granofszky M, et al. Among authors: larghero p. Haematologica. 2024 Mar 1;109(3):740-750. doi: 10.3324/haematol.2022.282424. Haematologica. 2024. PMID: 37345487 Free PMC article.
The KMT2A recombinome of acute leukemias in 2023.
Meyer C, Larghero P, Almeida Lopes B, Burmeister T, Gröger D, Sutton R, Venn NC, Cazzaniga G, Corral Abascal L, Tsaur G, Fechina L, Emerenciano M, Pombo-de-Oliveira MS, Lund-Aho T, Lundán T, Montonen M, Juvonen V, Zuna J, Trka J, Ballerini P, Lapillonne H, Van der Velden VHJ, Sonneveld E, Delabesse E, de Matos RRC, Silva MLM, Bomken S, Katsibardi K, Keernik M, Grardel N, Mason J, Price R, Kim J, Eckert C, Lo Nigro L, Bueno C, Menendez P, Zur Stadt U, Gameiro P, Sedék L, Szczepański T, Bidet A, Marcu V, Shichrur K, Izraeli S, Madsen HO, Schäfer BW, Kubetzko S, Kim R, Clappier E, Trautmann H, Brüggemann M, Archer P, Hancock J, Alten J, Möricke A, Stanulla M, Lentes J, Bergmann AK, Strehl S, Köhrer S, Nebral K, Dworzak MN, Haas OA, Arfeuille C, Caye-Eude A, Cavé H, Marschalek R. Meyer C, et al. Among authors: larghero p. Leukemia. 2023 May;37(5):988-1005. doi: 10.1038/s41375-023-01877-1. Epub 2023 Apr 5. Leukemia. 2023. PMID: 37019990 Free PMC article.
Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.
Burmeister T, Ströh AS, Kehden B, Trautmann H, Meyer C, Marschalek R, Larghero P, Schwartz S, Steffen B, Spriewald B, Heinicke T, Jäkel N, Westermann J, Nachtkamp K, Viardot A, Topp MS, Neumann M, Baldus CD, Gökbuget N, Brüggemann M. Burmeister T, et al. Among authors: larghero p. Leukemia. 2024 Jul;38(7):1600-1603. doi: 10.1038/s41375-024-02209-7. Epub 2024 Mar 22. Leukemia. 2024. PMID: 38519799 Free PMC article. No abstract available.
Erratum to: Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard risk acute myeloid leukemia.
Maurer-Granofszky M, Köhrer S, Fischer S, Schumich A, Nebral K, Larghero P, Meyer C, Mecklenbräuker A, Mühlegger N, Marschalek R, Haas OA, Panzer-Grümayer R, Dworzak MN. Maurer-Granofszky M, et al. Among authors: larghero p. Haematologica. 2024 Jul 1;109(7):2379-2381. doi: 10.3324/haematol.2024.285153. Haematologica. 2024. PMID: 38946650 Free PMC article. No abstract available.
The recombinome of IKZF1 deletions in B-cell precursor ALL.
Lopes BA, Meyer C, Bouzada H, Külp M, Maciel ALT, Larghero P, Barbosa TC, Poubel CP, Barbieri C, Venn NC, Pozza LD, Barbaric D, Palmi C, Fazio G, Saitta C, Aguiar TF, Lins MM, Ikoma-Colturato MRV, Schramm M, Chapchap E, Cazzaniga G, Sutton R, Marschalek R, Emerenciano M. Lopes BA, et al. Among authors: larghero p. Leukemia. 2023 Aug;37(8):1727-1731. doi: 10.1038/s41375-023-01935-8. Epub 2023 Jun 29. Leukemia. 2023. PMID: 37386080 No abstract available.
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia.
Külp M, Siemund AL, Larghero P, Dietz A, Alten J, Cario G, Eckert C, Caye-Eude A, Cavé H, Bardini M, Cazzaniga G, De Lorenzo P, Valsecchi MG, Diehl L, Bonig H, Meyer C, Marschalek R. Külp M, et al. Among authors: larghero p. iScience. 2022 Jun 16;25(7):104613. doi: 10.1016/j.isci.2022.104613. eCollection 2022 Jul 15. iScience. 2022. PMID: 35800767 Free PMC article.
Vaccine-induced COVID-19 mimicry syndrome.
Kowarz E, Krutzke L, Külp M, Streb P, Larghero P, Reis J, Bracharz S, Engler T, Kochanek S, Marschalek R. Kowarz E, et al. Among authors: larghero p. Elife. 2022 Jan 27;11:e74974. doi: 10.7554/eLife.74974. Elife. 2022. PMID: 35084333 Free PMC article.
45 results